There is no evidence that PUFA supplementation in infancy has an effect on infant or childhood allergy , asthma , dermatitis/eczema or food allergy .
However , the quality of evidence was very low .
There was insufficient evidence to determine an effect on allergic rhinitis
BACKGROUND Early dietary intakes may influence the development of allergic disease .
It is important to determine if dietary polyunsaturated fatty acids ( PUFAs ) given as supplements or added to infant formula prevent the development of allergy .
OBJECTIVES To determine the effect of higher PUFA intake during infancy to prevent allergic disease .
Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?
Abstract We compared growth of infants whose mothers either did or did not receive docosahexaenoic acid ( DHA ) supplements during pregnancy and lactation . At 21 weeks ' gestation , 144 women were enrolled into a r and omized , double-blind clinical trial receiving : ( 1 ) a basic supplement consisting of vitamins and minerals ( BS ) , or ( 2 ) BS plus 4.5 g fructooligosaccharide ( BSF ) , or ( 3 ) BSF plus fish oil DHA ( 200 mg ) until the end of the third month of lactation .  Infants ' length , weight and head circumference were measured at birth and at 1 , 3 and 21 months . A total of 51 mothers/infants were lost to follow-up by the third month and 24 at 21 months . The two groups not receiving DHA were combined into a control group . Analysis with mixed models adjusted for confounding factors showed a significant time dependent effect for the DHA group on the development of the body mass index ( BMI ) ( P=0.037 ) , and of weight ( P=0.046 ) , but no effect on the development of length ( P=0.537 ) , or of head circumference ( P=0.267 ) . At 21 months , weight of the  DHA group was lower by −601 g ( 95 % CI −171 ; −1030 g ) and BMI was lower by −0.76 kg/m2 ( 95 % CI −0.07 ; −1.46 ) compared to controls . The results indicate that DHA taken by pregnant and lactating mothers may reduce BMI in late infancy
There is no evidence that PUFA supplementation in infancy has an effect on infant or childhood allergy , asthma , dermatitis/eczema or food allergy .
However , the quality of evidence was very low .
There was insufficient evidence to determine an effect on allergic rhinitis
BACKGROUND Early dietary intakes may influence the development of allergic disease .
It is important to determine if dietary polyunsaturated fatty acids ( PUFAs ) given as supplements or added to infant formula prevent the development of allergy .
OBJECTIVES To determine the effect of higher PUFA intake during infancy to prevent allergic disease .